Keyphrases
Neutralizing Antibodies
100%
COVID-19
100%
Rapid Decline
100%
Ad26
100%
Omicron Variant
100%
Neutralizing Activity
66%
Titer
66%
Neutralizing Titer
66%
MRNA Vaccine
66%
S Vaccine
66%
BA.1
66%
Protective Immunity
33%
Vaccine Response
33%
Prototypic
33%
Prime-boost
33%
Peak Response
33%
Reduced Susceptibility
33%
D614G
33%
Heterologous Boosting
33%
Omicron Sub-lineages
33%
BA.3
33%
BA.2
33%
BA.2.12.1
33%
BA.4
33%
BA.5
33%
Short-term Durability
33%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
100%
Titer
100%
Neutralizing Antibody
100%
Messenger RNA
100%
Immunology and Microbiology
Neutralizing Antibody
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Omicron Coronavirus Variant
100%
Titer
66%
Neutralization
33%
Pharmacology, Toxicology and Pharmaceutical Science
Neutralizing Antibody
100%
SARS Coronavirus
100%
mRNA Vaccine
66%
Messenger RNA
66%